Dupuytren’s contracture release in adults
As part of the ongoing review of clinical policies for all the NHS Clinical Commissioning Groups (CCGs) in Lancashire and South Cumbria and following the statutory guidance issued by NHS England around 17 procedures included in their Evidence Based Interventions (EBI) guidance, we are now seeking your feedback on four additional clinical policies.
The patient access criteria for these policies has already been through a public consultation and been made mandatory guidance to Clinical Commissioning Groups. We are not therefore, seeking feedback on the criteria as this cannot be changed. The engagement being undertaken is to inform you about the new policies and to give you the opportunity to comment on any adverse impact you feel this will have and what the CCG should do to minimise this.
The draft policy for dupuytren’s contracture release in adults can be found below. You are invited to read the new clinical policy before giving your feedback. Your comments will be fed back to the CCG as part of the implementation process. None of the CCGs within Lancashire and South Cumbria have an existing policy for this treatment.
Futher down this page you will find some frequently asked questions which may answer any queries you have about the process or about this policy.
Your feedback should be submitted by Friday 1 February 2019.
Once you have read the new policy you can provide feedback through this online survey
If you have any further questions about this policy or the process being undertaken you can email email@example.com or ring 01772 214244.
If you require any of these documents in an alternative format such as Braille, larger print, audio, British Sign Language or in a language other than English please contact the Customer Care Team in one of the following ways:
Further opportunities will be made available for your involvement and feedback on other clinical policies as and when they are developed and available for discussion.
Frequently asked questions
These frequently asked questions are supplementary to the FAQ’s already identified as part of the clinical policy review process.